Buprenorphine Sublingual Tablets and Tofacitinib Extended-Release Tablets
Determining the interaction of Buprenorphine Sublingual Tablets and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Sublingual Tablets-Tofacitinib Tablets
- Buprenorphine Sublingual Tablets-Tofranil
- Buprenorphine Sublingual Tablets-Tofranil injection
- Buprenorphine Sublingual Tablets-Tofranil-PM
- Buprenorphine Sublingual Tablets-Tol-Tab
- Buprenorphine Sublingual Tablets-Tolazamide
- Tofacitinib Extended-Release Tablets-Buprenorphine Transdermal
- Tofacitinib Extended-Release Tablets-Buprenorphine Transdermal Patch
- Tofacitinib Extended-Release Tablets-Buprenorphine transdermal skin patch
- Tofacitinib Extended-Release Tablets-Buprenorphine, Buprenorphine Hydrochloride
- Tofacitinib Extended-Release Tablets-Buprenorphine/naloxone Oromucosal, Sublingual
- Tofacitinib Extended-Release Tablets-Buproban